Quantifying effects of ligands on androgen receptor nuclear translocation, intranuclear dynamics, and solubility

Journal of Cellular Biochemistry

Volumn 98, Issue 4, 2006, Pages 770-788

  Marcelli, Marco ^a,b   Stenoien, David L ^a   Szafran, Adam T ^a   Simeoni, Silvia ^a   Agoulnik, Irina U ^a   Weigel, Nancy L ^a   Moran, Tim ^e   Mikic, Ivana ^d   Price, Jeffrey H ^c,d   Mancini, Michael A ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c BURNHAM INSTITUTE   (United States)

^d VALA SCIENCES INC   (United States)

^e BECKMAN COULTER INC   (United States)

Author keywords

FRAP; GFP; High throughput microscopy; Nuclear receptor; Nuclear translocation

Indexed keywords

ANDROGEN RECEPTOR; BICALUTAMIDE; CYAN FLUORESCENT PROTEIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; GREEN FLUORESCENT PROTEIN; HYDROXYFLUTAMIDE; METRIBOLONE; MUTANT PROTEIN;

ARTICLE; CELL NUCLEUS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOPLASM; DNA BINDING; FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MICROSCOPY; MOLECULAR DYNAMICS; MUTATION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; SOLUBILITY;

ACTIVE TRANSPORT, CELL NUCLEUS; ANDROGEN ANTAGONISTS; ANILIDES; CELL NUCLEUS; DOSE-RESPONSE RELATIONSHIP, DRUG; HELA CELLS; HUMANS; LIGANDS; METRIBOLONE; MICROSCOPY, FLUORESCENCE; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, ANDROGEN;

EID: 33745611145     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.20593     Document Type: Article

References (34)

1. Czar MJ, Galigniana MD, Silverstein AM, Pratt WB. 1997. Geldanamycin, a heat shock protein 90-binding benzoquinone ansamycin, inhibits steroid-dependent translocation of the glucocorticoid receptor from the cytoplasm to the nucleus. Biochemistry 36:7776-7785.
2. Dong S, Stenoien DL, Qiu J, Mancini MA, Tweardy DJ. 2004. Reduced intranuclear mobility of APL fusion proteins accompanies their mislocalization and results in sequestration and decreased mobility of retinoid X receptor alpha. Mol Cell Biol 24:4465-4475.
3. Farla P, Hersmus R, Geverts B, Mari PO, Nigg AL, Dubbink HJ, Trapman J, Houtsmuller AB. 2004. The androgen receptor ligand-binding domain stabilizes DNA binding in living cells. J Struct Biol 147:50-61.
4. Fejes-Toth G, Pearce D, Naray-Fejes-Toth A. 1998. Subcellular localization of mineralocorticoid receptors in living cells: effects of receptor agonists and antagonists. Proc Natl Acad Sci USA 95:2973-2978.
5. Feldman BJ, Feldman D. 2001. The development of androgen-independent prostate cancer. Nat Rev Cancer 1:34-45.
6. Georget V, Lobaccaro JM, Terouanne B, Mangeat P, Nicolas JC, Sultan C. 1997. Trafficking of the androgen receptor in living cells with fused green fluorescent protein-androgen receptor. Mol Cell Endocrinol 129:17-26.
7. Htun H, Holth LT, Walker D, Davie JR, Hager GL. 1999. Direct visualization of the human estrogen receptor alpha reveals a role for ligand in the nuclear distribution of the receptor. Mol Biol Cell 10:471-486.
8. Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, Feuer EJ, Thun MJ. 2004. Cancer statistics, 2004. CA Cancer J Clin 54:8-29.
9. Jenster G, Trapman J, Brinkmann AO. 1993. Nuclear import of the human androgen receptor. Biochem J 293:761-768.
10. King WJ, Greene GL. 1984. Monoclonal antibodies localize oestrogen receptor in the nuclei of target cells. Nature 307:745-747.
11. Kopito RR. 2000. Aggresomes, inclusion bodies and protein aggregation. Trends Cell Biol 10:524-530.
12. Lamb DJ, Weigel NL, Marcelli M. 2001. Androgen receptors and their biology. Vitamines and Hormones 62:199-230.
13. Mancini MG, Liu B, Sharp ZD, Mancini MA. 1999. Subnuclear partitioning and functional regulation of the Pit-1 transcription factor. J Cell Biochem 72:322-338.
14. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schutz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P, et al. 1995. The nuclear receptor superfamily: the second decade. Cell 83:835-839.
15. Marcelli M, Ittmann M, Mariani M, Sutherland R, Nigam R, Murthy L, Zhou Y, DiConcini D, Puxeddu E, Esen A, Eastham J, Weigel NL, Lamb DJ. 2000. Androgen receptor mutations in prostate cancer. Can Res 60:944-949.
16. McKenna NJ, Lanz RB, O'Malley BW. 1999. Nuclear receptor coregulators: cellular and molecular biology. Endocr Rev 20:321-344.
17. McNally JG, Muller WG, Walker D, Wolford R, Hager GL. 2000. The glucocorticoid receptor: rapid exchange with regulatory sites in living cells. Science 287:1262-1265.
18. Nazareth LV, Stenoien DL, Bingman WE 3rd, James AJ, Wu C, Zhang Y, Edwards DP, Mancini M, Marcelli M, Lamb DJ, Weigel NL. 1999. A C619Y mutation in the human androgen receptor causes inactivation and mislocalization of the receptor with concomitant sequestration of SRC-1 (steroid receptor coactivator 1). Mol Endocrinol 13:2065-2075.
19. Nickerson JA, Blencowe BJ, Penman S. 1995. The architectural organization of nuclear metabolism. Int Rev Cytol 162A:67-123.
20. Phair RD, Misteli T. 2000. High mobility of proteins in the mammalian cell nucleus. Nature 404:604-609.
21. Phair RD, Scaffidi P, Elbi C, Vecerova J, Dey A, Ozato K, Brown D, Hager G, Bustin M, Misteli T. 2004. Global Nature of Dynamic Protein-Chromatin Interactions in vivo: Three-dimensional Genome Scanning and Dynamic Interaction Networks of Chromatin Proteins. Mol Cell Biol 24(14):6393-6402.
22. Reid P, Kantoff P, Oh W. 1999. Antiandrogens in prostate cancer. Invest New Drugs 17:271-284.
23. Rivera OJ, Song CS, Centonze VE, Lechleiter JD, Chatterjee B, Roy AK. 2003. Role of the Promyelocytic Leukemia Body in the Dynamic Interaction between the Androgen Receptor and Steroid Receptor Coactivator-1 in Living Cells. Mol Endocrinol 17:128-140.
24. Saitoh M, Takayanagi R, Goto K, Fukamizu A, Tomura A, Yanase T, Nawata H. 2002. The presence of both the amino- and carboxyl-terminal domains in the AR is essential for the completion of a transcriptionally active form with coactivators and intranuclear compartmentalization common to the steroid hormone receptors: a three-dimensional imaging study. Mol Endocrinol 16:694-706.
25. Sharp ZD, Stenoien DL, Mancini MG, Ouspenski II, Mancini MA. 2004. Inactivating Pit-1 mutations alter subnuclear dynamics suggesting a protein misfolding and nuclear stress response. J Cell Biochem 92:664-678.
26. Stenoien D, Sharp ZD, Smith CL, Mancini MA. 1998. Functional subnuclear partitioning of transcription factors. J Cell Biochem 70:213-221.
27. Stenoien DL, Cummings CJ, Adams HP, Mancini MG, Patel K, DeMartino GN, Marcelli M, Weigel NL, Mancini MA. 1999. Polyglutamine-expanded androgen receptors form aggregates that sequester heat shock proteins, proteasome components and SRC-1, and are suppressed by the HDJ-2 chaperone. Hum Mol Genet 8:731-741.
28. Stenoien DL, Mancini MG, Patel K, Allegretto EA, Smith CL, Mancini MA. 2000. Subnuclear trafficking of estrogen receptor-alpha and steroid receptor coactivator-1. Mol Endocrinol 14:518-534.
29. Stenoien DL, Nye AC, Mancini MG, Patel K, Dutertre M, O'Malley BW, Smith CL, Belmont AS, Mancini MA. 2001a. Ligand-mediated assembly and real-time cellular dynamics of estrogen receptor alpha-coactivator complexes in living cells. Mol Cell Biol 21:4404-4412.
30. Stenoien DL, Patel K, Mancini MG, Dutertre M, Smith CL, O'Malley BW, Mancini MA. 2001b. FRAP reveals that mobility of oestrogen receptor-alpha is ligand- and proteasome-dependent. Nat Cell Biol 3:15-23.
31. Tomura A, Goto K, Morinaga H, Nomura M, Okabe T, Yanase T, Takayanagi R, Nawata H. 2001. The sub-nuclear three-dimensional image analysis of androgen receptor fused to green fluorescence protein. J Biol Chem 276:28395-28401.
32. Tsai MJ, O'Malley BW. 1994. Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu Rev Biochem 63:451-486.
33. Tyagi RK, Lavrovsky Y, Ahn SC, Song CS, Chatterjee B, Roy AK. 2000. Dynamics of intracellular movement and nucleocytoplasmic recycling of the ligand-activated androgen receptor in living cells. Mol Endocrinol 14:1162-1174.
34. Welshons WV, Cormier EM, Wolf MF, Williams PO Jr., Jordan VC. 1988. Estrogen receptor distribution in enucleated breast cancer cell lines. Endocrinology 122:2379-2386.